613 related articles for article (PubMed ID: 6100644)
41. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.
Depper JM; Leonard WJ; Krönke M; Noguchi PD; Cunningham RE; Waldmann TA; Greene WC
J Immunol; 1984 Dec; 133(6):3054-61. PubMed ID: 6092466
[TBL] [Abstract][Full Text] [Related]
42. Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells.
Greene WC; Robb RJ; Depper JM; Leonard WJ; Drogula C; Svetlik PB; Wong-Staal F; Gallo RC; Waldmann TA
J Immunol; 1984 Aug; 133(2):1042-7. PubMed ID: 6330200
[TBL] [Abstract][Full Text] [Related]
43. Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes.
Reed JC; Tadmori W; Kamoun M; Koretzky G; Nowell PC
J Immunol; 1985 Mar; 134(3):1631-9. PubMed ID: 2981917
[TBL] [Abstract][Full Text] [Related]
44. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
Malek TR; Robb RJ; Shevach EM
J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
[TBL] [Abstract][Full Text] [Related]
45. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
[TBL] [Abstract][Full Text] [Related]
46. IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.
Taylor DS; Kern JA; Nowell PC
J Immunol; 1986 Mar; 136(5):1620-4. PubMed ID: 3005396
[TBL] [Abstract][Full Text] [Related]
47. Cell surface phenotype and in vitro function of adult T-cell leukemia cells.
Uchiyama T; Hattori T; Wano Y; Tsudo M; Takatsuki K; Uchino H
Diagn Immunol; 1983; 1(3):150-4. PubMed ID: 6094084
[TBL] [Abstract][Full Text] [Related]
48. Human retrovirus-induced IL-2 receptors and their possible role in transduction of continuous cell growth signal.
Sugamura K; Fujii M; Sakitani M; Kobayashi N; Nakai S; Hatanaka M; Hinuma Y
Princess Takamatsu Symp; 1984; 15():269-76. PubMed ID: 6100645
[TBL] [Abstract][Full Text] [Related]
49. Antigen-specific and -nonspecific mitogenic signals in the activation of human T cell clones.
Nisbet-Brown ER; Lee JW; Cheung RK; Gelfand EW
J Immunol; 1987 Jun; 138(11):3713-9. PubMed ID: 2953789
[TBL] [Abstract][Full Text] [Related]
50. Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells.
Ueda R; Nishida K; Koide Y; Tsuge I; Seto M; Yoshida M; Miyoshi I; Ota K; Takahashi T
Cancer Res; 1985 Mar; 45(3):1314-9. PubMed ID: 2578877
[TBL] [Abstract][Full Text] [Related]
51. Growth of human T lymphocytes: an analysis of interleukin 2 and its cellular receptor.
Greene WC; Leonard WJ; Depper JM
Prog Hematol; 1986; 14():283-301. PubMed ID: 2418464
[No Abstract] [Full Text] [Related]
52. Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.
Abo T; Miller CA; Balch CM; Cooper MD
J Immunol; 1983 Oct; 131(4):1822-6. PubMed ID: 6413578
[TBL] [Abstract][Full Text] [Related]
53. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
Schwab R; Crow MK; Russo C; Weksler ME
J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
[TBL] [Abstract][Full Text] [Related]
54. The tumor promoter teleocidin induces IL 2 receptor expression and IL 2-independent proliferation of human peripheral blood T cells.
Isakov N; Bleackley RC; Shaw J; Altman A
J Immunol; 1985 Oct; 135(4):2343-50. PubMed ID: 3928744
[TBL] [Abstract][Full Text] [Related]
55. Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
Reed JC; Greene WC; Hoover RG; Nowell PC
J Immunol; 1985 Oct; 135(4):2478-82. PubMed ID: 3928749
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous increased expression of E-rosette receptor (CD2, T11) and T cell growth factor receptor on human T lymphocytes during activation.
Redelman D
Cytometry; 1987 Mar; 8(2):170-83. PubMed ID: 3107949
[TBL] [Abstract][Full Text] [Related]
57. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
58. VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation.
Hemler ME; Jacobson JG; Brenner MB; Mann D; Strominger JL
Eur J Immunol; 1985 May; 15(5):502-8. PubMed ID: 2986987
[TBL] [Abstract][Full Text] [Related]
59. Effect of T3 modulation on pokeweed mitogen-induced T cell activation: evidence for an alternative pathway of T cell activation.
Ceuppens JL; Meurs L; Baroja ML; Van Wauwe JP
J Immunol; 1986 May; 136(9):3346-50. PubMed ID: 3007616
[TBL] [Abstract][Full Text] [Related]
60. In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.
Lotze MT; Custer MC; Sharrow SO; Rubin LA; Nelson DL; Rosenberg SA
Cancer Res; 1987 Apr; 47(8):2188-95. PubMed ID: 3030546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
